● BREAKING NEWS
HealthBiz
search
Menu
INTERVIEWS Nov 05, 2026 · min read

India's Fertility Industry Needs a New Growth Model: Transparency, Technology and Patient-Centred IVF Care

Team HealthBiz

HealthBiz

India's Fertility Industry Needs a New Growth Model: Transparency, Technology and Patient-Centred IVF Care

Fertility & Reproductive Healthcare | IVF | Healthcare Business | India

India's fertility and assisted reproductive technology (ART) sector is entering a new phase of development. Increasing awareness of infertility, delayed parenthood, changing family structures and growing demand for fertility preservation are creating opportunities for specialised fertility clinics and reproductive healthcare providers.

However, the industry's next stage of growth will depend on more than expanding the number of IVF centres or increasing treatment volumes.

Patients are increasingly looking for transparent pricing, reliable clinical information, personalised care and better communication throughout what can often be a physically and emotionally demanding treatment journey.

This shift is encouraging fertility providers to rethink how reproductive healthcare is organised, delivered and measured.

Moving Beyond Traditional IVF Clinic Models

For many patients, fertility treatment involves multiple consultations, investigations, hormonal injections, monitoring appointments and clinical procedures.

The process can become difficult to navigate, particularly when patients have to coordinate appointments, understand treatment protocols and manage medication schedules alongside their professional and personal responsibilities.

Traditional clinic models have often concentrated primarily on clinical procedures and treatment outcomes.

The emerging patient-centred approach seeks to integrate clinical care with navigation, communication, convenience and emotional support.

Dedicated care coordinators, digital treatment records, medication reminders and structured patient communication are becoming important elements of this model.

The objective is to ensure that patients understand each stage of treatment and know whom to contact when they need assistance.

Transparency in IVF Outcomes: Why Live Birth Rates Matter

One of the most important issues facing the fertility industry is the way treatment success is communicated to patients.

IVF providers may use different parameters when reporting success rates. Some may refer to a positive pregnancy test, while others may report clinical pregnancy or live birth outcomes.

These measurements are not interchangeable.

A positive pregnancy test does not necessarily mean that a pregnancy will progress to live birth. Similarly, success rates can vary considerably depending on patient age, ovarian reserve, infertility diagnosis, treatment history and the denominator used for calculation.

For patients comparing fertility centres, headline success-rate figures without adequate explanation can therefore be misleading.

The industry needs more consistent and transparent reporting practices.

Important parameters include:

  • Positive pregnancy rate.

  • Clinical pregnancy rate.

  • Ongoing pregnancy rate.

  • Live birth rate.

  • Outcomes by age group.

  • Outcomes by treatment type.

  • Results per initiated cycle and per embryo transfer.

  • Cancellation rates and treatment discontinuation.

  • Patient experience and satisfaction.

Reporting should clearly explain the measurement method, patient population and relevant limitations.

Transparency should also include unsuccessful treatment cycles rather than highlighting only favourable outcomes.

A more consistent approach would help patients make informed decisions and encourage greater accountability across fertility providers.

Fertility Preservation: An Expanding Healthcare Opportunity

Fertility preservation is emerging as an important area of reproductive healthcare.

Egg freezing, also known as oocyte cryopreservation, allows women to preserve eggs for potential future use.

The procedure may be considered by women who wish to delay childbearing, as well as those facing certain medical treatments that could affect fertility.

Embryo freezing is another established fertility-preservation option for eligible patients.

Despite growing awareness, many people remain unfamiliar with these possibilities, their limitations and the appropriate time to seek medical advice.

Importantly, egg freezing does not guarantee a future pregnancy or live birth. Outcomes depend on several factors, including age at freezing, the number and quality of eggs obtained, and future treatment circumstances.

Fertility awareness programmes, informed counselling and access to reproductive specialists can help individuals understand their options without creating unrealistic expectations or unnecessary pressure.

Affordability Remains a Major Barrier

The financial burden of fertility treatment continues to influence access to reproductive healthcare.

IVF may involve several cost components, including:

  • Initial consultations and investigations.

  • Hormonal stimulation medicines.

  • Ultrasound and laboratory monitoring.

  • Egg retrieval procedures.

  • Embryology and laboratory services.

  • Embryo transfer.

  • Cryopreservation and storage.

  • Additional treatment cycles where required.

Patients may find it difficult to understand the total potential expenditure when prices are presented separately or when additional procedures become necessary.

Fertility providers can improve transparency by offering itemised treatment estimates, clearly explaining what is included and identifying costs that may arise during treatment.

Structured payment plans and EMI facilities may also help eligible patients manage expenses, although affordability should not come at the cost of compromising clinical standards.

Corporate Fertility Benefits: A New Employee Healthcare Category

Employer-sponsored fertility benefits represent another emerging opportunity for the healthcare industry.

As organisations increasingly focus on employee wellbeing, reproductive health is gradually becoming part of broader workplace healthcare discussions.

Potential benefits may include fertility consultations, diagnostic assessments, fertility preservation support, IVF assistance and access to specialist counselling.

Such programmes could help employees understand reproductive health options earlier and reduce some of the financial barriers associated with treatment.

For employers, fertility benefits may also form part of wider diversity, inclusion and employee-retention strategies.

However, these programmes need appropriate privacy safeguards. Reproductive health information should remain confidential and should not influence employment decisions.

Technology Is Reshaping the Fertility Patient Journey

Technology is becoming an important operational component of modern fertility clinics.

IVF treatment involves several time-sensitive activities, including medication administration, injections, ultrasound monitoring and laboratory procedures.

Digital platforms can help coordinate these activities and improve communication between patients and clinical teams.

Potential applications include:

Digital treatment calendars: Patients can access their treatment schedules, medication instructions and upcoming appointments.

Medication reminders: Automated reminders can help patients follow prescribed medication schedules.

Electronic medical records: Reports, laboratory findings and treatment history can be maintained in a centralised digital record.

Patient communication platforms: Secure messaging and appointment coordination can improve access to clinic support.

Clinical workflow systems: Technology can help medical teams monitor treatment progress and coordinate different stages of IVF.

Artificial intelligence may also contribute to selected areas of fertility research and clinical workflow optimisation. However, its use must be supported by appropriate clinical validation and professional oversight.

Technology should simplify the patient journey rather than replace the expertise of reproductive medicine specialists and embryologists.

Psychological Counselling and Nutrition: The Importance of Holistic Fertility Care

Infertility can have significant emotional and psychological consequences.

Repeated treatment cycles, uncertainty about outcomes, financial pressures and social expectations can affect patients and couples in different ways.

Integrating psychological counselling into fertility services can help patients manage stress, understand treatment decisions and cope with unsuccessful cycles.

Nutrition and lifestyle counselling may also form part of preconception healthcare, based on individual clinical needs.

A comprehensive fertility-care model should recognise that patients are not simply undergoing a medical procedure. They are navigating a complex healthcare experience that requires clinical expertise, communication and emotional sensitivity.

Importantly, psychological support should complement medical treatment and should never imply that stress or emotional factors are responsible for infertility.

Scaling Fertility Clinics Without Compromising Clinical Standards

The expansion of fertility networks creates an important operational challenge.

A clinic that delivers a good patient experience at one location must be able to maintain the same standards as it opens additional centres.

This requires more than replicating infrastructure and branding.

Fertility providers need standardised clinical protocols, trained reproductive medicine specialists, qualified embryologists, laboratory quality-control systems and consistent patient communication processes.

Laboratory performance, equipment maintenance, infection control and documentation are equally important.

Regulatory compliance under India's Assisted Reproductive Technology (Regulation) Act, 2021 and the associated rules must remain central to the expansion strategy.

The challenge is to achieve operational scalability without reducing individualised clinical care.

Building Trust Through Patient Experience Measurement

Clinical outcomes remain central to fertility treatment, but they are not the only indicators of healthcare quality.

The patient experience also deserves systematic measurement.

Fertility providers could evaluate:

  • Waiting times and appointment accessibility.

  • Clarity of treatment explanations.

  • Transparency of billing.

  • Availability of clinical support.

  • Timeliness of communication.

  • Patient privacy and confidentiality.

  • Access to psychological counselling.

  • Patient feedback and grievance resolution.

These indicators can help providers identify operational weaknesses and improve service delivery.

A transparent patient-feedback system may also strengthen trust between healthcare providers and patients.

The Business Outlook for India's Fertility Sector

India's fertility market offers opportunities across several interconnected segments.

These include specialised IVF centres, embryology laboratories, fertility preservation services, reproductive diagnostics, cryopreservation infrastructure, digital fertility platforms and corporate reproductive healthcare programmes.

The industry may also see greater interest in integrated models that combine clinical treatment, patient navigation, counselling and technology-enabled care.

For investors and healthcare entrepreneurs, the long-term opportunity will depend on building financially sustainable operations while maintaining clinical quality and ethical standards.

Centres that focus exclusively on increasing treatment volumes may find it difficult to build lasting patient trust.

Those that combine transparent communication, evidence-based treatment, operational efficiency and responsible expansion could be better positioned for sustainable growth.

The Road Ahead

India's fertility sector is gradually moving towards a model in which patients expect more than access to IVF procedures.

They want to understand their treatment options, know the financial implications, receive appropriate counselling and have clear information about the likely outcomes and limitations of treatment.

For healthcare providers, this represents an opportunity to redefine fertility services around measurable clinical quality and a better patient experience.

Standardised outcome reporting, accessible fertility preservation, transparent pricing, digital care coordination and stronger regulatory compliance will be important priorities.

The future of fertility healthcare in India will not be determined simply by how many IVF cycles clinics perform, but by how responsibly they deliver treatment, communicate outcomes and earn the trust of patients.

Neha Motwani, Founder and CEO, Luma Fertility, published October 24, 2026. This is an independent HealthBiz editorial analysis and does not constitute an endorsement of Luma Fertility or its services.

Written by

Team HealthBiz